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Abstract: Background: Human Papillomavirus (HPV) is a common sexually transmitted infection
(STI), representing the main cause of genital warts and cervical cancer. This cross-sectional study
evaluated knowledge and attitudes about HPV infection, related diseases, and prevention and
propensity towards HPV vaccine among undergraduate students. Methods: An online and written
survey about HPV and its prevention, targeted to young adults of both genders, was addressed to
students attending health sciences and other schools at Universities of Genoa and Bari. Results: The
overall median knowledge and attitude scores were 56.3% (25–75 p = 40–68.8%) and four out of five
(25–75 p = 4–5), respectively. In the multivariate analysis, attending a health sciences university, using
social networks ≤2 h a day, a history of STI, having heard about HPV and HPV vaccine previously
resulted as predictors of higher knowledge scores. Having heard about HPV previously also predicted
a high attitude score, together with a perceived economic status as good. Having Italian and healthcare
worker parents, being employed, and following a specific diet, instead, predicted lower attitude score.
Conclusions: Poor knowledge and good attitudes were found among undergraduates about HPV. In
order to increase HPV vaccine compliance and the counselling skills of future healthcare workers, the
improvement of training on HPV is needed.
Keywords: HPV; knowledge; practice; attitude; young adults; vaccination; student; prevention;
sexually transmitted infection
1. Introduction
Human papillomavirus (HPV) infection is recognized as the most common STI worldwide [1,2].
HPV infection is acquired soon after sexual debut, it is transient and cleared at an early age [3]. If
persistent, it can lead to a wide range of benign lesions and cancers, affecting the ano-genital and the
oropharyngeal tract in both sexes [4]. Of note, official epidemiological estimates report 570,000 cases
and 311,000 deaths due to cervical cancer in 2018 worldwide, placing the disease as the fourth most
frequently diagnosed cancer and the fourth leading cause of cancer death in women [5]. The risk factors
involved in the evolution of HPV-related diseases are the efficiency of the host’s immune response and
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the characteristics of the virus, including the genotype, the presence of multiple HPV infections, the
viral load and integration in the host genome [6]. Co-factors related to the development of ano-genital
cancers are alcohol, smoking, and the presence of co-infections with other pathogens [7,8].
Data acquired in recent years confirm that HPV vaccines and screening are the most effective
prevention tools [9]; in particular, solid evidence is accumulating about vaccine effectiveness,
long-lasting protection, and economic benefits in the avoiding cases [10,11]. Indeed vaccination
programs have been implemented in 74 countries all over the world (33 countries in the WHO
European Region) targeting girls and 11 targeted to boys, achieving successful results [12]. In Italy, the
HPV vaccine started in 2007, with a strategy of active call and free-of-charge vaccines targeting girls
aged 11–12 years [13]. Then the vaccination program was extended to males aged 11–12 years and
at-risk subjects (men who engage in same-sex sexual behaviors) [14,15] following the latest evidence
about the cost-effectiveness of HPV vaccination in other targets [16]. Furthermore, women aged
25 years, at the moment of cervical cancer screening can benefit from the HPV vaccine, as recommended
by the National Vaccine Plan 2017–2019.
Despite this prevention opportunity, the coverage rate is still suboptimal in Italy, as in other
countries, due to HPV vaccination uptake barriers, such as inadequate knowledge of HPV infection and
related diseases, vaccination safety concerns, organizational aspects of HPV vaccine campaigns, and
difficulties in vaccine schedule completion for subjects and providers [17]. In order to investigate the
level of knowledge of HPV infection and vaccination, as well as the attitudes towards recommending the
anti-HPV vaccine, an ad hoc knowledge and attitudes questionnaire was developed and administered
to Italian young adult students.
2. Materials and Methods
2.1. Study Design and Participants
A cross-sectional multicenter survey about HPV and its prevention, targeted to young adults
of both genders, was carried out from May 2017 to December 2018. The study population included
females who retain the right to free-charge vaccination, males who can benefit from the vaccine in
co-payment regimens, and subjects at risk, like those who are HIV-positive and men who have sex
with men. Recruitment of the study participants took place at the University of Genoa (Liguria region,
Northwest Italy), University of Bari (Apulia region, Southern Italy), and the San Martino Hospital
in Genoa. In particular, subjects were recruited among students attending healthcare profession
schools (i.e., nurses and healthcare assistants) who are required to periodically undergo a medical
examination at occupational health surveillance outpatient clinics and who are attending academic
schools including public health and prevention subjects in the first and second academic years. The
study staff enrolled the students at the outpatient clinic and on the occasion of academic lessons.
The sample size was calculated considering the number of subjects belonging to the target study
population, the at-risk subjects, and healthcare personnel, the available evidence about the HPV vaccine
acceptability fixing the confidence interval at 95%, a margin of error (+/−) of 2.5%, and adding a quota
of 5%, in consideration of the possible drop-outs and missed answers.
2.2. Data Collection and Questionnaire
Ad hoc anonymous questionnaires addressed to young adults were developed. They were
self-administered using the Google Drive platform that automatically populates and saves digital
responses into a secure Microsoft Excel database protecting participant confidentiality throughout the
surveying process. A consent page reporting the study aims and objectives, the participant’s right
to the refusal or the possibility to terminate the participation in the study at any time and without
disadvantages was created.
Participants could also fill two written informed consent and questionnaires characterized by
the same structure of those administered online. The first questionnaire was set in two sections: the
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first one investigated the country of parent’s birth, level of parent’s education, parent’s occupation,
and, for the participant, demographics, level of education, occupation, economic status, professed
religion, healthy behavior, such as following a specific nutritional regimen (diet) and sport practice,
sexual behaviors and orientation, use of the Internet and social networks, the sources used for seeking
information on sexually transmitted diseases (STDs), including HPV, and remembering about vaccines
received during childhood. The first section also included a 10-point Likert scale ranking the interest to
receive an HPV vaccine. The second section included 13 questions on the knowledge on HPV infection,
related diseases, and vaccine. The second questionnaire assessed their attitude using nine statements
with a five-point Likert scale for each one (5 points- Strongly Agree, 4 point-Agree, 3 points-Neutral,
2 points-Disagree, 1 points-Strongly Disagree). It also included a 10-point Likert scale on how much
the participant was interested to receive HPV vaccine after reading some information on HPV infection,
related diseases, and vaccine included at the beginning of the second questionnaire (self-learning).
Based on the participants’ responses, the knowledge, attitude, and intention scores were calculated.
The ‘knowledge’ score summarizes the percentage of correct answers the participants gave among the
knowledge questions. For each knowledge statement, one point was given for a correct answer (true
or false) and zero points if they selected a wrong answer or “Do not know”. The total points were
added for every participant and a percentage was calculated (number of correct answers/number of
knowledge statements× 100). The higher the knowledge score, the more knowledgeable the participant
is regarding HPV infection, its related diseases, and prevention. The attitude score was obtained by
calculating the average of the participants’ responses to the statements on a five-point Likert scale. The
median of the total points was calculated for every participant obtaining an attitude score ranging
from 1.0 to 5.0. The closer the attitude score to 5, the more positive the participant’s attitudes. The
“intention” score reflects the propensity toward the HPV vaccine. The “intention” score was estimated
both at the beginning and at the end of the survey, when the information about HPV infection and
vaccination had been given. The score is a scale from 1 to 10, where 10 reflects the highest propensity
toward the HPV vaccine.
2.3. Statistical Analyses
Statistical analysis was performed by means of JMP software (SAS, NC), version 13 and Microsoft
Excel, version 2016 after generating data from the written questionnaires and Google Drive (CA, USA).
Median and 25–75 percentiles for continuous variables, frequencies, and percentages for categorical
variables were calculated. The possible association of baseline characteristics of young adults with
knowledge and attitude scores was tested through univariable logistic regression. A p-value less than
0.05 was considered significant throughout the study. Multivariate logistic regression analysis was
performed to identify the predictors of having high knowledge score or positive attitude score towards
HPV vaccination. Only covariates that showed a significance level of p-value < 0.1 in the univariate
analysis were included in the multivariable regression model, using a backward stepwise algorithm.
Given the high number of potential independent variables, a backward stepwise algorithm was used to
identify the best-fitting subset of variables to use in the final regression model. In particular, Akaike’s
Information Criterion (AIC) was used to assess the models’ fit and the model with the lowest AIC was
selected for the multivariable analysis. β-coefficients (95% C.I.) and p-values were estimated.
2.4. Ethics Approval and Consent to Participate
In complying with the highest ethical standards, participants were informed that their participation
was entirely voluntary and that they could withdraw at any moment. All data obtained through their
participation was kept strictly confidential among the research team. In addition, an informed consent
was obtained after explaining the nature of the study and its possible consequences of it. The study
protocol was approved by the Liguria Regional Ethics Committee (P.R. 162REG2017) for the study
coordination center.
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3. Results
3.1. Participants’ Characteristics
A total of 680 young adults returned the self-administered questionnaires, giving a response rate of
100%. Table 1 shows the participants’ baseline characteristics. The median age of the participants was
20 (25–75 p = 19–21), 65.2% were female and 95.9% were Italian. A total of 97.1% declared to be students
and only 2.9% were employed. A total of 24.5% of subjects had a graduate parent and 10.4% had at
least one parent who was a health care operator. A total of 53.3% of the subjects consider their own
economic status as good. As regards lifestyle habits, 23.1% and 56.6% of participants follow a specific
diet and practice sports, respectively. Furthermore, 65% and 49.6% of young adults surfed the Internet
and used the social networks up to 2 h a day, respectively. Among sexual habits, 61.8% of subjects had
a partner at the time of the survey and 83.8% used contraceptive methods, the most reported of which
was condom use (61.7% of cases). Furthermore, 97.2% of participants were heterosexual. The median
age of sexual debut and number of partners in the last year were 17 (25–75 p = 16–18) and 1 (25–75
p = 1–1), respectively.
Table 1. Baseline characteristics of the study’s participants.











Italian parents 515 (75.74)
NR 146 (21.47)
Educational qualification of parents
Primary School Certificate 2 (0.39)
Secondary School Certificate 153 (29.94)
High School Diploma 231 (45.21)
University Degree 125 (24.46)
NR 169 (24.85)
Parents employed 507 (74.56)
NR 159 (23.38)
Parents healthcare worker 50 (10.35)
Student 660 (97.06)
NR 20 (2.94%)
University students 597 (90.45)









Physical activity 385 (56.62)
Surf the web
≤2 h 436 (64.98)
3–4 h 184 (27.42)
≥5 h 51 (7.6)
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Table 1. Cont.
N (%) Median (25–75 p)
Use of social network
≤2 h 330 (49.55)
3–4 h 233 (34.98)







Sexual Partner 12 (1.76)
Sexual Partner 420 (61.76)
Use of contraceptive methods 352 (83.81)
Type of contraceptive method
Condom 217 (61.65)
Oral contraceptive 112 (31.82)
Vaginal ring 25 (7.10)





Sexual Partners in the last year 1 (1–1)
Age of first sexual intercourse 17 (16–18)
Lifetime sexual partners 2 (1–4)
History of immunodeficiencies 18 (2.65)
History of STIs 33 (4.85)
History of HPV related lesions 15 (2.21)
Frequencies and percentages for categorical variables and median and 25–75 percentiles for continuous variables,
were calculated. Abbreviations: Non-responded, NR; sexually transmitted infections, STIs.
3.2. Sources of Information about HPV
A total of 80.4% of subjects had heard about HPV vaccine before the survey, in particular from a
family member (43.7% of cases), Internet (24% of cases), teachers (25.1% of cases), and LHAs informative
material (23.6% of cases) (Table 2).
Table 2. Sources of information about HPV.
Variables N (%)
Ever heard about HPV 578 (85.00)
Ever heard about HPV vaccine 547 (80.44)
Family member 239 (43.69)
Internet 131 (23.95)
Teacher 137 (25.05)
Information from the Local Health Agency 129 (23.58)
Healthcare workers of a vaccine center 69 (12.61)






Other specialist doctor 21 (3.84)
Other Healthcare professionals 21 (3.84)
Sexual Partner 16 (2.93)
Colleagues 10 (1.83)
Pharmacist 6 (1.10)
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Table 2. Cont.
Variables N (%)
Favourite source of information on HPV vaccines
Trusted doctor 387 (56.91)
Internet 330 (48.53)
Books/paper material 105 (15.44)
Friends 24 (3.53)
Frequencies and percentages for categorical variables and median and 25–75 percentiles for continuous variables,
were calculated.
3.3. Knowledge of HPV Infection, Related Diseases, and Prevention
The overall median knowledge score was 56.3% (25–75 p = 40–68.8).
Most of the subjects answered correctly the statement that HPV is sexually transmitted (82.4%)
and that using condoms reduces the risk of HPV infection (86.2%) (Table 3). Only 40.3% knew that
HPV infection can be transmitted during pregnancy and delivery from mother to the child. Among
risk factors of exposure to HPV infection, only about 50% of participants recognized the early sexual
debut. A total of 77.5% of the subjects knew that HPV infects both females and males, but only 21.4%
and 54% correlates HPV to penile and cervical cancers, respectively. In terms of benign diseases, the
information that HPV can cause genital warts is known by 42.8% of subjects, and 80.4% are aware
that both females and males can develop them. Only 52.7% and 48.7% of subjects are aware that HPV
infection is widespread and can be transmitted by asymptomatic carriers. Furthermore, 40.9% of
participants think that most infected subjects develop cancer. As regards HPV therapy, only 23.4% of
participants knew that no specific treatments are available. Finally, 67.8% and 58.8% of young adults
correctly answered the questions related to the indication of HPV vaccine targeting both females and
males and the efficacy of HPV vaccine in adults who already had a sexual debut.
Table 3. Study’s participants’ knowledge about HPV infection, related diseases, and prevention.
Knowledge Statement Response Correct Do not Know Wrong
N % N % N %
HPV infection is transmitted through sexual intercourse True 560 82.35 95 13.97 25 3.68
If yes, early sexual debut increases the risk of contracting HPV True 263 46.96 127 22.68 170 30.36
If yes, using condoms reduces the risk of HPV transmission True 481 86.20 56 9.7 23 4.12
If yes, a high number of sexual partners increases the risk of
contracting HPV True 383 68.39 97 17.33 80 14.28
HPV infection can be transmitted from mother to child during
pregnancy and during delivery True 274 40.29 292 42.94 114 16.77
HPV can infect both males and females True 527 77.50 − − 153 22.50
Disease associated with HPV in men: penile cancer True 114 21.39 221 41.46 198 37.14
Disease associated with HPV in women: cervical cancer True 367 53.97 172 25.29 141 20.74
HPV can lead to genital warts True 291 42.79 334 49.12 55 8.1
If yes, genital warts affect both male and female True 234 80.41 − − 57 19.58
HPV infection is widespread True 358 52.65 246 36.18 76 11.17
Most HPV infected people develop cancer False 118 17.35 278 40.88 284 41.76
HPV infection can be transmitted from a carrier to his/her
partner only if the carrier shows symptoms False 331 48.67 207 30.44 142 20.88
A person may be HPV-infected and not be aware of it True 452 66.47 180 26.47 48 7.06
There are no specific therapies for HPV infection True 159 23.38 319 46.91 202 29.71
Both males and females can be vaccinated against HPV True 461 67.79 3 0.44 216 31.76
The HPV vaccine is also effective in after starting sexual activity True 400 58.82 199 29.27 81 11.91
For each knowledge statement, the correct answer is reported. Frequencies and percentages of correct, wrong and
unknown answers were calculated.
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Table 4 shows the results of univariable logistic regression investigating the possible association
between the characteristics of the participant young adults and the knowledge score. Variables
significantly related to higher knowledge scores are: attending a healthcare university (p < 0.0001),
using social networks up to 2 h a day (p = 0.0215), history of sexual transmitted infection and of
HPV-related lesions (p = 0.0349 and p = 0.0290, respectively), and having heard about HPV before the
survey (p = 0.0035). Furthermore, family members and mass media as source of information about
HPV are significantly related to worse knowledge scores (p = 0.0501 and p = 0.0762, respectively).
Gynecologists, instead, are reported as a source of information by young adults with significantly
higher knowledge scores (p = 0.0014).
Table 4. Participants’ knowledge and attitude scores stratified by their characteristics.
Characteristics
Knowledge Score p-Value Attitude Score p-Value
Median (25–75 p) Median (25–75 p)
Sex
0.7976 0.0053Female 56.3 (40–68.8) 4.5 (4–5)
Male 53.3 (38.5–68.8) 4 (4–5)
Birthplace
0.0716 0.7724Italy 56.3 (40–68.8) 4 (4–5)





No 50 (33.3–62.5) 4.5 (4–5)
Educational qualification of parents
0.6626 0.6358
Primary School Certificate 44.85 (25–64.7) 4.5 (4–5)
Secondary School Certificate 52.9 (38–62.5) 4 (4–5)
High School Diploma 53.3 (38.5–66.7) 4 (4–5)
University Degree 56.3 (40–68.8) 4 (4–5)




No 50 (42.85–63.05) 4 (4–4.13)




No 53.3 (37.5–62.5) 4 (4–5)
University students
<0.0001 0.2365Health sciences 62.5 (50–80) 4.5 (4–5)





No 56.3 (40–68.8) 4.5 (4–5)
Economic status
0.3755Acceptable 53.3 (38.5–68.8) 4 (4–5)
0.0031Good 56.3 (40–68.8) 4.5 (4–5)





No 56.3 (40–68.8) 4.5 (4–5)




No 56.3 (39.63–68.8) 4.5 (4–5)
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Table 4. Cont.
Characteristics
Knowledge Score p-Value Attitude Score p-Value
Median (25–75 p) Median (25–75 p)
Surf the web
0.9326 0.4214≤2 h 56.3 (40–68.8) 4 (4–5)
3–4 h 56.3 (40–68.8) 4 (4–5)
≥5 h 53.3 (40–64.3) 4 (4–5)
Use of social network
0.0215 0.0115≤2 h 56.3 (42.9–68.8) 4.5 (4–5)
3–4 h 53.3 (38.5–68.8) 4 (4–5)





No 56.3 (37.5–68.8) 4 (4–5)
Cohabitants
0.5603 0.4981
Parents 56.3 (40–66.7) 4 (4–5)
Friends 53.1 (31.8–76.13) 4.5 (4–5)
Alone 64.6 (32.85–82.4) 4.5 (4–5)
Sexual Partner 52.75 (33.3–64.15) 4 (4–4.5)




No 56.3 (40–68.8) 4 (4–5)




No 56.3 (35.7–73.3) 4 (4–5)
Sexual orientation
0.3461 0.0841Heterosexual 56.3(40–68.8) 4 (4–5)
Bisexual 52.9 (36.5–59.4) 5 (4–5)
Homosexual 72.8 (35.95–88.2) 4.75 (4–5)
Sexual Partners in the last year
0.5801 0.13980–2 56.3 (40–68.8) 4 (4–5)
≥ 3 52.9 (38.75–69.7) 5 (4–5)
Age of first sexual intercourse
0.4739 0.476713–14 54.8 (35.1–65.2) 4.5 (4–5)
15–17 53.3 (38.25–68.8) 4 (4–5)
≥ 18 56.3 (41.7–68.8) 4 (4–5)
Lifetime sexual partners
0.1491 0.19290–3 56.3 (38.5–68.28) 4 (4–5)
≥ 4 56.3 (40–68.8) 4.5 (4–5)




No 56.3 (40–68.8) 4 (4–5)




No 56.3 (40–68.8) 4 (4–5)




No 56.3 (40–68.8) 4 (4–5)
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Table 4. Cont.
Characteristics
Knowledge Score p-Value Attitude Score p-Value
Median (25–75 p) Median (25–75 p)




No 46.7 (33.3–62.95) 4 (3.5–4.3)




No 50 (34.5–62.5) 4 (3.75–4.5)
Source of information on HPV
vaccine














No 56.3 (40–68.8) 4.5 (4–5)
Information from the Local Health
Agency 58.8 (46.2–70.6) 0.1671
4.5 (4–5)
0.0081
No 56.3 (40–68.8) 4.5 (4–5)
Healthcare workers of a vaccine
center 56.3 (43.8–62.5) 0.2754
4.5 (4–5)
0.6951
No 56.3 (41.27–70.6) 4.5 (4–5)
























No 56.3 (40–68.8) 4.5 (4–5)
For each knowledge statement, one point was given for a correct answer (true or false) and zero points if a
wrong answer or “Do not know” was reported. The knowledge score is the number of correct answers/number
of knowledge statements × 100. Attitude score of each subject was estimated through a five-point Likert scale
(5 points—Strongly Agree, 4 point-Agree, 3 points-Neutral, 2 points-Disagree, 1 points-Strongly Disagree) and
is the median of the total points was calculated for every participant (range =1.0 to 5.0). The univariable logistic
regression tested the possible association of baseline characteristics of young adults with knowledge and attitude
scores. A p-value less than 0.05 was considered significant.
3.4. Attitudes about HPV Infection and Prevention
The overall median attitude score was as high as 4 (25–75 p = 4–5). Only 49.7% of participants
agree or strongly agree that during the own life he/she will have high probability to be exposed to HPV
infections (Table 5). A total of 93.8% of subjects, instead, are aware that HPV can cause serious diseases.
As regards the favorite source of information and opinion to get vaccinated, the most reported were
trusted doctors (85.3%) and teachers (90.4%), followed by parents and partners (51.8% and 39.9%,
respectively). About safety concern, 76.5% of partipants believe that HPV vaccine is safe. Furthermore,
83.5% agree or strongly agree to have their own child vaccinated.
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Agree Agree Neutral Disagree Strongly Disagree
n % n % n % n % n %
I believe that Papillomavirus
(HPV) can cause serious diseases 380 55.88 258 37.94 29 4.26 8 1.17 5 0.74
I believe that I will be exposed to
HPV infection during my life 77 11.32 261 38.38 225 33.09 89 13.09 28 4.12
I believe anti-HPV vaccines are
capable of preventing the
occurrence of cervical cancer and
genital warts
338 49.70 280 41.18 56 8.24 6 0.88 −
I believe the anti-HPV vaccination
must be mandatory for boys and
girls before the sexual debut and
for at risk subjects
332 48.82 238 35.10 84 12.39 16 2.36 10 1.48
I believe my parents’ favorable
opinion is essential to decide to get
vaccinated against HPV *
114 18.57 204 33.22 169 27.52 83 13.52 44 7.16
I believe that the favorable opinion
of my partner is essential to decide
to get vaccinated against HPV
77 11.32 194 28.53 175 25.73 128 18.82 106 15.59
I believe it is useful to talk to my
doctor about HPV infections and
other sexually transmitted
infections
243 35.73 337 49.55 87 12.79 8 1.18 5 0.73
I believe it is useful to talk about
HPV infections and other sexually
transmitted infections at school
364 53.53 251 36.91 58 8.53 5 0.73 2 0.29
I believe if I have children I get
them vaccinated against HPV 324 47.65 244 35.88 102 15 10 1.47 −
I believe the anti-HPV vaccine is
safe 218 32.1 302 44.41 139 20.44 17 2.5 4 0.59
Legend: * N. 66 (9.71%) subjects did not answer. For each attitude statement, the answer is reported. Frequencies
and percentages of “strongly agree”, “agree”, “neutral”, “disagree”, “strongly disagree” answers were calculated.
Table 4 shows the results of univariable logistic regression investigating the possible association
between the characteristics of the participant young adults and the attitude score. Significantly higher
attitude scores were reported among subjects with foreign parents, without parents who are healthcare
workers (p = 0.0103), who are not employed (p = 0.0211), who reported a good economic status
(p = 0.0031), who do not follow a specific diet (p = 0.0004), who use social network up to 2 h a day
(p = 0.0115), those without immunodeficiencies (p = 0.0381), and those who heard about HPV before
the survey (p < 0.0001). As regards the source of information about HPV vaccine, subjects who reported
teachers, LHAs informative material, pediatricians/general practitioners, had significantly higher
attitude scores (p = 0.0100, p = 0.0081, and p = 0.0061, respectively).
3.5. Propensity toward HPV Vaccination
The median propensity score before and after the educational intervention was stable and high as
9 (25–75 p = 8–10).
3.6. Multivariate Analysis
The results of the multivariate analysis predicting high knowledge and attitude scores are presented
in Tables 6 and 7, respectively. The predictors of high knowledge are attending Healthcare University,
using social network ≤2 h/day, having a history of STIs, and having heard about HPV and anti-HPV
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vaccine before the survey. As regards predictors of high attitude score, a good economic status and
having heard about HPV before the survey are predicted to have more positive attitudes towards HPV
vaccine, while having Italian parents, being employed, and a parent who is/was a healthcare worker
are predicted to have worse attitudes. Both the models significantly help in predicting knowledge and
attitude scores since the p-values of the F-test are <0.0001.






University: health sciences 6.713 4.508 8.918 <0.0001
Use of social network ≤2 h/day 2.691 0.547 4.834 0.0141
History of STIs 4.208 0.114 8.302 0.0440
Ever heard about HPV 8.789 2.397 15.181 0.0072
Ever heard about HPV vaccine 6.061 1.262 10.859 0.0135
Covariates significant at 0.1 in the univariate analysis were evaluated for inclusion in multivariable regression
model, using a backward stepwise algorithm.






Italian parents −0.1548 −0.3031 −0.0065 0.0408
Worker −0.0911 −0.1610 −0.0213 0.0106
Economic status: good 0.0713 0.0178 0.1246 0.0089
Diet −0.1473 −0.2126 −0.0821 <0.0001
Ever heard about HPV 0.1715 0.1018 0.2413 <0.0001
Parents healthcare worker −0.1132 −0.2001 −0.0263 0.0108
Covariates that were significant at 0.1 in the univariate analysis were evaluated for inclusion in multivariable
regression model, using a backward stepwise algorithm.
4. Discussion
To the best of our knowledge, this is one of the first studies to quantitatively investigate knowledge
and attitudes about HPV, and propensity towards HPV vaccination before and after a formative moment,
in young adults students of both genders living in a high gross domestic product (GDP) country such
as Italy, where a dynamicity in the objectives and targets of HPV vaccination by public health since its
introduction in 2007 was observed. This study was performed not only in undergraduates attending
health sciences schools, but also in other university students.
Young adults are a category at risk of sexually transmitted HPV infection. Since HPV has
a causative role in serious and frequent diseases, such as cancers and genital warts, respectively,
interventions to prevent low and high-risk types of HPV infections are urgently warranted; indeed,
vaccinating both men and women against HPV is crucial to protect against HPV-related cancers and
other diseases.
Recent international recommendation on HPV vaccination have included additional age classes,
not only adolescents of both genders (aged 11–12 years), but also females 13–26 years-old who have not
been previously vaccinated or who have not completed the vaccine series, and males aged 13–21 years
and 22–26 years with special conditions or who want to protect themselves from the disease [17,18].
The current Italian National Vaccine Prevention Plan (NVPP) 2017–2019 extended the vaccination
program to include pre-adolescent males (aged between 11 and 12 years) and at-risk subjects (men
who engage in same-sex sexual behaviors) [14]. Furthermore, the NVPP recommends a multi-cohort
immunization strategy, preferably targeting 25 years-old young adult females who begin cervical
cancer screening. Based on the current vaccination plans and the need to implement knowledge and
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attitude of young adults of both gender, an overall approach is desired. Indeed, it is of note that HPV
coverage rates are suboptimal in both genders in many developed countries, including Italy [19].
An evaluation of what young adults know about the threat of HPV and believe about HPV
prevention can offer possible solutions to remedy the underutilization of the HPV vaccine in a
population at high risk for contracting this preventable infection and to explore innovative strategies.
The findings are, therefore, relevant at the light of better understanding and comparing educational
needs and attitudes toward HPV infection and prevention in one of the HPV vaccine targets [20–22].
Furthermore, the interviewed subset including health sciences students, allowed estimating knowledge
needs and main attitudes of future healthcare workers and counsellors.
Our findings highlight, on one side, insufficient knowledge of undergraduate students on HPV
infection and HPV- related diseases, on the other side, a substantial positive attitude toward the vaccine.
Gaps on HPV knowledge were detected in previous studies enrolling study population similar to our
study population for demographic characteristics [23–26]. In our survey, a not negligible percentage of
students had low consciousness about the impact of HPV infection in terms of spread, the routes of
infection, and risk factors, such as early sexual debut, the role of HPV in causing penile cancer and
genital warts, and the unavailability of specific therapeutic treatment. This would confirm the need to
promote educational programs for young subjects and introducing changes in the current curriculum
of university students attending health sciences schools, in order to increase understanding about HPV
of future healthcare professionals. However, as expected, higher knowledge was detected in health
sciences students’ respect to undergraduates attending other academic course (p < 0.0001). Results
worthy of highlighting are that more than 93% affirmed that HPV can be implicated in developing
serious disease but only 49.7% consider themselves at risk of exposure to HPV. These results are
comparable with those described by Villanueva et al. who recently investigated knowledge, attitudes,
and intentions towards HPV among nursing students in Spain [25]. As regards attitudes towards HPV
vaccine, more than 90% and 76% of participants consider HPV vaccine effective and safe, respectively.
In a very recent Italian cross-sectional study that assessed nursing students’ knowledge and attitudes
about HPV infection and vaccination, only 20.5% of subjects considered very safe the HPV vaccine [27].
The abovementioned Spanish study also investigated attitudes towards HPV vaccine efficacy and safety,
finding that 66.5% and 65.4% of students agree or strongly agree that HPV is capable of preventing the
occurrence of cervical cancer and that side effects are reasonable, respectively [25]. We also investigated
the willingness of participants considered as potential future parents to get their own child immunized
against HPV and only 83.5% agree or strongly agree with this sentence. This observation is of concern
since it demonstrates that the high consciousness of the causal role of HPV in determining serious
diseases, such as cancers, is not a sufficient factor in determining recommended vaccine compliance.
Among young adults characteristics, parents’ nationality, educational qualification, and
employment were investigated in relation to knowledge and attitude scores. The knowledge score
resulted higher, although not statistically significant, in young adults with healthcare worker parents,
while the attitude score was higher for subjects with parents who are employed in other sectors. This
observation could be linked to the well-known largely suboptimal compliance of healthcare workers to
vaccines [28,29]. Furthermore, considering the parents’ nationality, knowledge scores of young subjects
was similar between those with Italian parents and those without. On the contrary, the attitude score
was higher in those with foreigner parents (p = 0.0491), who mainly come from developing countries.
A possible explanation could be a better propensity by the foreign families towards Italian healthcare
services, including prevention. As regards lifestyles, the young who follow specific nutritional regimen
had significantly lower attitude score (p = 0.0044), confirmed by multivariate analysis (p < 0.0001),
this could be explained by the fact that those who engage in specific behaviors oriented around ‘the
natural’ is often hesitant or refuse vaccines [30]. Surprisingly, physical activity was related neither
to higher knowledge nor to attitude scores. Although healthy lifestyles are expected to be related to
better compliance to preventive measures. Among sexual habits, 83.8% of subjects who had a partner
at the time of the survey (61.8% of participating young adults) used contraceptive methods, the most
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represented of which was condom use (61.7%), followed by oral contraceptive (31.8%). Furthermore,
the median age of sexual debut was 17 (25–75 p = 16–18), with a median of lifetime sexual partners
of 2 (25–75 p = 1–4). These findings are substantially comparable with the observations obtained
in other European countries [22,25]. Considering sexual orientation, 1.3% and 1.5% were bisexual
and homosexual, respectively. Of relevance, homosexual surveyed subjects demonstrated higher
knowledge than heterosexual and bisexual subjects, although this result has to be interpreted with
caution because of the scarce number of surveyed homosexual and bisexual subjects. A possible
explanation could be the higher attention toward to health and prevention tools by homosexuals.
History of STIs and HPV-related lesions was also investigated, showing that only 4.9% and 2.2% of
subjects were diagnosed for the abovementioned diseases, respectively. Furthermore, the history of
STIs was found as predictor of high knowledge score at the multivariate analysis (p = 0.0440). This
observation could be linked to the previous contact of affected subjects with the healthcare system
which could have favored the acquisition of knowledge on this topic.
Before the educational moment, subjects were asked to declare if they have heard about HPV
previously. Our findings revealed that a high percentage of young (80%) already knew this infection,
which is well up rates reported in other published research [31–33] and significantly predicts both
higher knowledge and attitude scores (p = 0.0072 and p < 0.001). In particular, family members,
Internet, teachers, and LHAs’ informative material were the most frequently reported sources of
information. Surfing the web and the use of social networks were also investigated, showing that using
social network ≤2 h/day is among the predictors of better knowledge on HPV compared to higher use
(p = 0.0141). This finding suggests that social networks can also disseminate misleading messages
on HPV. Nevertheless, the increasing pervasiveness of social media, such as Facebook, as powerful
communication channels means that they can potentially be used to effectively reach young people.
Therefore, public health should better communicate messages through existing networks and engage
in on-going dialogue with users [34–36].
Our study also deepened attitudes regarding the favorite sources of information about HPV of
participating subjects, finding that talking about HPV with teachers and trusted doctor is considered
very useful by young adults, while only 51.8% and 39.9% of participants believe that parents’ and
partner’s opinions are essential to decide to get vaccinated against HPV. These answers confirm the
role of physicians and teachers recognized by young adults in spreading health information including
sensitive topics such as STIs. Of note, the majority of participants (83.92%) agree or strongly agree to
make compulsory HPV vaccine for boys and girls before the sexual debut and for at risk subjects. This
is of interest in countries such as Italy where a recent law introduced the compulsory of some vaccines,
excluding HPV [37].
In order to evaluate the efficacy of educational intervention in implementing the propensity of
young adults toward HPV vaccine, we estimated it through a score before and after the administration
of a written text summarizing the available evidences on HPV infection, related diseases and prevention.
The score resulted very high (median = 9, 25–75 p = 8–10) and remained stable after the educational
session. A recent meta-analysis that assessed the effectiveness of interventions targeting HPV vaccine
initiation and completion among children, adolescents, and young adults aged 9–26 years support
behavioral and informational interventions, including education (e.g., exercises, audit and feedback,
video intervention, peer/medical narrative), educational websites tailored to baseline knowledge, and
brochures/factsheets, for HPV vaccine initiation and behavioral interventions for completion [38].
Considering the surveyed subset of health sciences students, and their future role in counselling on
prevention themes, a comparison with the results of a recent published study by Berenson et al. could
be conducted. The authors assessed the effects of an educational program by means of a single lecture
and delivered by an expert and found that this can improve medical students’ attitudes and comfort
with HPV vaccine counseling [39]. This evidence suggests that short educational interventions are
already efficacious, but the presence of an expert open to discussion allows obtaining better results
than reading informative material alone.
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The study limits are the nature of self-reported data collected from the participants, which may be
compromised by the respondents’ memory of experiences of interest. Furthermore, since northern and
southern regions were involved in the enrollments, the representativeness of young adults living in the
Central Italian regions is lacking. Despite these limitations, this survey obtained a very high response
rate, demonstrating the strong interest in HPV topic. As regards education, the self-learning session
could be improved by focus groups and other interactive methods. Nevertheless, academic public
health teaching includes HPV burden and prevention among treated themes.
5. Conclusions
The results of the current study demonstrates that Italian undergraduates show suboptimal
knowledge on HPV and good attitudes. Since they represent both the target of HPV vaccine and
future healthcare workers, the implementation of training about HPV infection, its related diseases,
and prevention tools are needed to support the important role they play in the prevention of STIs,
some of which are related to the occurrence of cancer. Universities represent a privileged setting to
spread information about HPV to the target audience and young adults recognize teachers together
with trusted doctors as the favorite source of information. Improving students’ knowledge may have
favorable implications in increasing vaccine coverage rates.
Author Contributions: Conceptualization:, C.T. and G.I.; Methodology: C.T. and F.A.; Formal analysis: C.T.;
Investigation: S.T., L.S., P.D. and A.M.B.; Resources: S.T., L.S., P.D. and A.M.B.; Data curation: C.T., F.V. and
B.D.S.; Writing—Original draft preparation: C.T. and C.C.; Writing—Review and editing: C.T., F.A., G.I and D.A.;
Supervision: F.A. and G.I.; Project administration: C.T. and G.I. All authors have read and agreed to the published
version of the manuscript.
Funding: The research was conducted with the support of Sanofi Pasteur MSD, who funded a fixed-term contract
for an assistant professor in public health. The funding sources neither influenced the design of the study nor the
analysis of the results.
Acknowledgments: The authors would like to thank the students attending Universities of Genoa and Bari for
their participation in the study.
Conflicts of Interest: Giancarlo Icardi is the principal investigator of this national multicenter study. The research
staff included the fixed-term assistant professor funded by Sanofi Pasteur MSD. The other authors have no known
competing financial interests nor personal relationships that could have appeared to influence the work reported
in this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of
data; in the writing of the manuscript; or in the decision to publish the results.
References
1. Satterwhite, C.L.; Torrone, E.; Meites, E.; Dunne, E.F.; Mahajan, R.; Ocfemia, M.C.; Su, J.; Xu, F.; Weinstock, H.
Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sex.
Transm. Dis. 2013, 40, 187–193. [CrossRef] [PubMed]
2. WHO. Human Papillomavirus (HPV) and Cervical Cancer. Available online: https://www.who.int/news-
room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer (accessed on 20 October 2019).
3. Bosch, F.X.; de Sanjosé, S. Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of
causality. J. Natl. Cancer Inst. Monogr. 2003, 31, 3–13. [CrossRef] [PubMed]
4. Serrano, B.; Brotons, M.; Bosch, F.X.; Bruni, L. Epidemiology and burden of HPV-related disease. Best Pract.
Res. Clin. Obstet. Gynaecol. 2018, 47, 14–26. [CrossRef] [PubMed]
5. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018:
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J.
Clin. 2018, 68, 394–424. [CrossRef] [PubMed]
6. Schiffman, M.; Kjaer, S.K. Chapter 2: Natural history of anogenital human papillomavirus infection and
neoplasia. J. Natl. Cancer Inst. Monogr. 2003, 31, 14–19. [CrossRef] [PubMed]
7. Winkelestein, W., Jr. Smoking and cancer of the uterine cervix: Hypotesis. Am. J. Epidemiol. 1977, 106,
257–259. [CrossRef]
8. Prokopczyk, B.; Cox, J.E.; Hoffmann, D.; Waggoner, S.E. Identification of tobacco specific carcinogen in the
cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 1997, 89, 868–873. [CrossRef]
Vaccines 2020, 8, 74 15 of 16
9. Brotherton, J.M.L. Impact of HPV vaccination: Achievements and future challenges. Papillomavirus Res. 2019,
7, 138–140. [CrossRef]
10. Kent, A. HPV Vaccination and Testing. Rev. Obstet. Gynecol. 2010, 3, 33–34.
11. Prue, G.; Baker, P.; Graham, D.; Nutting, C.; Greenhouse, P.; Lawler, M. It is time for universal HPV
vaccination. Lancet 2018, 392, 913–914. [CrossRef]
12. WHO. Regional Office for Europe. Available online: http://www.euro.who.int/__data/assets/pdf_file/0010/
356842/QA_HPV_General_EN.pdf (accessed on 20 October 2019).
13. Ministero Della Salute. Campagna di Comunicazione Contro il Papilloma Virus-2008. Available
online: http://www.salute.gov.it/portale/news/p3_2_6_1_1.jsp?lingua=italiano&menu=campagne&p=
dacampagne&id=42 (accessed on 20 October 2019).
14. Intesa tra il Governo, le Regioni e le Province Autonome di Trento e Bolzano sul Documento recante “Piano
Nazionale Prevenzione Vaccinale (PNPV) 2017–2019”. Intesa ai Sensi Dell’Articolo 8, Comma 6, Della Legge 5
Giugno. 2003, n. 131. Available online: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
(accessed on 20 October 2019).
15. Soe, N.N.; Ong, J.J.; Ma, X.; Fairley, C.K.; Latt, P.M.; Jing, J.; Cheng, F.; Zhang, L. Should human papillomavirus
vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted
literature review of cost-effectiveness. Hum. Vaccine Immunother. 2018, 14, 3010–3018. [CrossRef] [PubMed]
16. Ng, S.S.; Hutubessy, R.; Chaiyakunapruk, N. Systematic review of cost-effectiveness studies of human
papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination.
Vaccine 2018, 36, 2529–2544. [CrossRef] [PubMed]
17. Kim, D.K.; Hunter, P.; Advisory Committee on Immunization Practices. Recommended Adult Immunization
Schedule, United States, 2019. Ann. Intern. Med. 2019, 170, 182. [CrossRef] [PubMed]
18. Saslow, D.; Andrews, K.S.; Manassaram-Baptiste, D.; Loomer, L.; Lam, K.E.; Fisher-Borne, M.; Smith, R.A.;
Fontham, E.T.; American Cancer Society Guideline Development Group. Human papillomavirus vaccination
guideline update: American Cancer Society guideline endorsement. CA Cancer J. Clin. 2016, 66, 375–385.
[CrossRef] [PubMed]
19. Trucchi, C.; Costantino, C.; Restivo, V.; Bertoncello, C.; Fortunato, F.; Tafuri, S.; Amicizia, D.; Martinelli, D.;
Paganino, C.; Piazza, M.F.; et al. Immunization Campaigns and Strategies against Human Papillomavirus in
Italy: The Results of a Survey to Regional and Local Health Units Representatives. Biomed Res. Int. 2019, 4,
6764154. [CrossRef] [PubMed]
20. Herman, R.; McNutt, L.A.; Mehta, M.; Salmon, D.A.; Bednarczyk, R.A.; Shaw, J. Vaccination perspectives
among adolescents and their desired role in the decision-making process. Hum. Vaccine Immunother. 2019,
15, 1752–1759. [CrossRef]
21. Caskey, R.; Lindau, S.T.; Alexander, G.C. Knowledge and early adoption of the HPV vaccine among girls and
young women: Results of a national survey. J. Adolesc. Health 2009, 45, 453–462. [CrossRef]
22. Jeannot, E.; Viviano, M.; Follonier, M.C.; Kaech, C.; Oberhauser, N.; Mpinga, E.K.; Vassilakos, P.; Kaiser, B.;
Petignat, P. Human Papillomavirus Infection and Vaccination: Knowledge, Attitude and Perception among
Undergraduate Men and Women Healthcare University Students in Switzerland. Vaccines 2019, 7, 130.
[CrossRef]
23. Topan, A.; Ozturk, O.; Eroglu, H.; Bahadir, O.; Harma, M.; Harma, M.I. Knowledge level of working and
student nurses on cervical cancer and human papilloma virus vaccines. Asian Pac. J. Cancer Prev. 2015, 16,
2515–2519.
24. Uzunlar, Ö.; Özyer, Ş.; Başer, E.; Toğrul, C.; Karaca, M.; Güngör, T. A survey on human papillomavirus
awareness and acceptance of vaccination among nursing students in a tertiary hospital in Ankara, Turkey.
Vaccine 2013, 31, 2191–2195. [CrossRef]
25. Villanueva, S.; Mosteiro-Miguéns, D.G.; Domínguez-Martís, E.M.; López-Ares, D.; Novío, S. Knowledge,
Attitudes, and Intentions towards Human Papillomavirus Vaccination among Nursing Students in Spain.
Int. J. Environ. Res. Public Health 2019, 16, 4507. [CrossRef] [PubMed]
26. Dany, M.; Chidiac, A.; Nassar, A.H. Human papillomavirus vaccination: Assessing knowledge, attitudes,
and intentions of college female students in Lebanon, a developing country. Vaccine 2015, 33, 1001–1007.
[CrossRef] [PubMed]
Vaccines 2020, 8, 74 16 of 16
27. Pelullo, C.P.; Esposito, M.R.; Di Giuseppe, G. Human Papillomavirus Infection and Vaccination: Knowledge
and Attitudes among Nursing Students in Italy. Int. J. Environ. Res. Public Health 2019, 16, 1770. [CrossRef]
[PubMed]
28. Genovese, C.; Picerno, I.A.M.; Trimarchi, G.; Cannavò, G.; Egitto, G.; Cosenza, B.; Merlina, V.; Icardi, G.;
Panatto, D.; Amicizia, D.; et al. Vaccination coverage in healthcare workers: A multicenter cross-sectional
study in Italy. J. Prev. Med. Hyg. 2019, 60, E12–E17. [PubMed]
29. Durando, P.; Alicino, C.; Dini, G.; Barberis, I.; Bagnasco, A.M.; Iudici, R.; Zanini, M.; Martini, M.; Toletone, A.;
Paganino, C.; et al. Determinants of adherence to seasonal influenza vaccination among healthcare workers
from an Italian region: Results from a cross-sectional study. BMJ Open 2016, 6, e010779. [CrossRef] [PubMed]
30. Attwell, K.; Smith, D.T.; Ward, P.R. The Unhealthy Other’: How vaccine rejecting parents construct the
vaccinating mainstream. Vaccine 2018, 36, 1621–1626. [CrossRef] [PubMed]
31. Blake, K.D.; Ottenbacher, A.J.; Finney Rutten, L.J.; Grady, M.A.; Korbrin, S.C.; Jacobson, R.M.; Hesse, B.W.
Predictors of human papillomavirus awareness and knowledge 2013: Gaps and opportunities for targeted
communication strategies. Am. J. Prev. Med. 2015, 48, 402–410. [CrossRef]
32. McBride, K.R.; Singh, S. Predictors of Adults’ Knowledge and Awareness of HPV, HPV-Associated Cancers,
and the HPV Vaccine. Health Educ. Behav. 2018, 45, 68–76. [CrossRef]
33. Sherman, S.M.; Nailer, E.; Minshall, C.; Coombes, R.; Copper, J.; Redman, C.W. Awareness and knowledge of
HPV and cervical cancer in female students: A survey (with a cautionary note). J. Obstet. Gynaecol. 2016, 36,
76–80. [CrossRef]
34. Subasinghe, A.K.; Nguyen, M.; Wark, J.D.; Tabrizi, S.N.; Garland, S.M. Targeted Facebook Advertising is a
Novel and Effective Method of Recruiting Participants into a Human Papillomavirus Vaccine Effectiveness
Study. JMIR Res. Protoc. 2016, 5, e154. [CrossRef]
35. Keelan, J.; Pavri, V.; Balakrishnan, R.; Wilson, K. An analysis of the Human Papilloma Virus vaccine debate
on MySpace blogs. Vaccine 2010, 28, 1535–1540. [CrossRef] [PubMed]
36. Amicizia, D.; Domnich, A.; Gasparini, R.; Bragazzi, N.L.; Lai, P.L.; Panatto, D. An overview of current
and potential use of information and communication technologies for immunization promotion among
adolescents. Hum Vaccine Immunother. 2013, 9, 2634–2642. [CrossRef] [PubMed]
37. Ministero della Salute. Decreto legge 7 giugno 2017, n. 73, Disposizioni Urgenti in Materia di Prevenzione
Vaccinale, Come Modificato Dalla Legge di Conversione 31 Luglio. 2017, n. 119. Available online:
http://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=60201 (accessed on 23 January 2020).
38. Rodriguez, A.M.; Do, T.Q.N.; Goodman, M.; Schmeler, K.M.; Kaul, S.; Kuo, Y.F. Human papillomavirus
vaccine interventions in the U.S.: A systematic review and metaanalysis. Am. J. Prev. Med. 2019, 56, 591–602.
[CrossRef] [PubMed]
39. Berenson, A.B.; Hirth, J.M.; Fuchs, E.L.; Chang, M.; Rupp, R.E. An educational intervention to improve
attitudes regarding HPV vaccination and comfort with counseling among US medical students. Hum. Vaccine
Immunother. 2019, 6, 1–6. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
